A monoclonal antibody reactive with a 40-kDa molecule on fetal thymocytes and tumor cells blocks proliferation and stimulates aggregation and apoptosis

Journal of Immunology

Volumn 163, Issue 3, 1999, Pages 1306-1314

  Fernandes, Dancella M ^a   Baird, Allison M ^a   Berg, Leslie J ^a   Rock, Kenneth L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ANIMAL CELL; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CELL AGGREGATION; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; FETUS; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; MOLECULE; NONHUMAN; PRIORITY JOURNAL; THYMOCYTE; TUMOR CELL; TUMOR CELL CULTURE;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; APOPTOSIS; CELL AGGREGATION; CELL DEATH; CELL LINE, TRANSFORMED; CRICETINAE; CRICETULUS; FETUS; GLYCOSYLPHOSPHATIDYLINOSITOLS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; LYMPHOMA, T-CELL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR WEIGHT; PRECIPITIN TESTS; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0033179392     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Furth, J., H. R. Siebold, and R. R. Rathbone. 1933. Experimental studies on lymphomatosis of mice. Am. J. Cancer 19:521.
2. Famulari, N. G. 1983. Murine Leukemia viruses with recombinant env genes: a discussion of their role in leukemogenesis. Curr. Top. Microbiol. Immunol. 103: 75.
3. Donnell, P. O., E. Stockert, Y. Obata, and L. J. Old. 1981. Leukemogenic properties of AKR dual tropic (MCF) viruses: amplification of murine leukemia virus-related antigens on thymocytes and acceleration of leukemia development in AKR mice. Virology 112:548.
4. Pederson, F. S., R. L. Crowther, D. Y. Tenney, A. M. Reimold, and W. A. Haseltine. 1981. Novel leukaemogenic retroviruses isolated from a cell line derived from spontaneous AKR tumor. Nature 292:167.
5. Lenz, J., and W. A. Haseltine. 1983. Localization of the leukemogenic determinants of SLR3-3, an ecotropic, XC-positive murine leukemia virus of AKR mouse origin. J. Virol. 47:317.
6. - thymic T lymphoma cell line to stimulation by thymic cellular elements. J. Immunol. 147:42.
7. Karre, K., H. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defense strategy. Nature 319:675.
8. Lanier, L. L., and N. L. Warner. 1981. Cell cycle related heterogeneity of Ia antigen expression on a murine lymphoma cell line: analysis by flow cytometry. J. Immunol. 126:626.
9. Fidler, I. J., D. M. Gersten, and M. B. Budmen. 1976. Characteristics in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity. Cancer Res. 36:3160.
10. Hou, S., L. Hyland, L. M. Bradley, S. R. Watson, and P. C. Doherty. 1995. Subverting lymph node trafficking by treatment with Mel-14 monoclonal antibody to L-selectin does not prevent an effective host response to Sendai virus. J. Immunol. 155:252.
11. Dailey, L., and C. Basilico. 1985. Sequences in the polyomavirus DNA regulatory region involved in viral DNA replication and early gene expression. J. Virol. 54:739.
12. Graham, F. L., and J. Smiley. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59.
13. Gorer, P. A., and D. B. Amos. 1956. Passive immunity in mice against C57BL leukosis E.L.4 by means of iso-immune sera. Cancer Res. 16:338.
14. Ralph, P., M. A. S. Moore, and K. Nilsson. 1976. Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J. Exp. Med. 143:1528.
15. Mizel, S. B., J. J. Oppenheim, and D. L. Rosenstreich. 1978. Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. 1. Enhancement of LAF production by activated T lymphocytes. J. Immunol. 120:1497.
16. DeMars, R., C. C. Chang, S. Shaw, P. J. Reitnauer, and P. M. Sondel. 1984. Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens. Hum. Immunol. 11:77.
17. 2 phase has a temperature-sensitive ubiquitin-activating enzyme E1. J. Biol. Chem. 263: 15726.
18. Bierhuizen, M. F. A., and M. Fukuda. 1992. Expression cloning of a cDNA encoding UDP-GlcNAc:Galβ1-3-GalNAc-R (GlcNAc to GalNAc) β1-6Glc-NAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen. Proc. Natl. Acad. Sci. USA 89:9326.
19. Weiss, A., R. L. Wiskocil, and J. D. Stobo. 1984. The role of T3 surface molecules in the activation of human T cells: a two stimulus requirement for IL-2 production reflects events occurring at a pre-translational level. J. Immunol. 133: 123.
20. Hartzell, S. W., B. J. Byrne, and K. N. Subramanian. 1984. Mapping of the late promoter of simian virus 40. Proc. Natl. Acad. Sci. USA 81:23.
21. Gluzman, Y. 1981. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23:175.
22. Wiblin, C. N., and I. A. MacPherson. 1972. The transformation of BHK-21 hamster cells by simian virus 40. Int. J. Cancer 10:296.
23. Consigli, R. A., and H. S. Ginsberg. 1964. Activity of aspartate transcarbamylase in uninfected and type 5 adenovirus-infected HeLa cells. J. Bacteriol. 87:1034.
24. - thymic T cell line. Cell. Immunol. 155:144.
25. + B cell hybridomas to H-2-restricted T cell hybridomas. Proc. Natl. Acad. Sci. USA 79:3604.
26. Kim, K. J., C. Kanellopoulos-Langevin, D. H. Sachs, and R. Asofsky. 1979. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J. Immunol. 122:549.
27. Vidard, L., K. L. Rock, and B. Benacerraf. 1991. The generation of immunogenic peptide scan be selectively increased or decreased by proteolytic enzyme inhibitors. J. Immunol. 147:1786.
28. Kovacsovics-Bankowski, M., and K. L. Rock. 1994. Presentation of exogenous antigens by macrophages : analysis of major histocompatibility complex class I and II presentation. Eur. J. Immunol. 24:2421.
29. Shimonkevitz, R., J. Kappler, P. Marrack, and H. Grey 1983. Antigen recognition by H-2-restricted T cells. I. Cell-free antigen. J. Exp. Med. 158:303.
30. Vidard, L., K. L. Rock, and B. Benacerraf. 1992. Diversity in MHC class II ovalbumin T cell epitopes generated by distinct proteases. J. Immunol. 149:498.
31. Rock, K. L., L. Rothstein, and S. Gamble. 1990. Generation of class I MHC restricted T-T hybridomas. J. Immunol. 145:804.
32. Shen, Z., G. Reznikoff, G. Dranoff, and K. L. Rock. 1997. Cloned dendritic cells ca present exogenous antigens on both class I and class II molecules. J. Immunol. 158:2723.
33. Gillis, S., and K. A. Smith. 1977. Long term culture of tumor-specific cytotoxic T cells. Nature 268:154.
34. Watson, J. 1979. Continuous proliferation of murine antigen-specific helper T lymphocytes in culture. J. Exp. Med. 150:1510.
35. Peterson, M., and J. Miller. 1990. Invariant chain influences the immunological recognition of MHC class II molecules. Nature 345:172.
36. Hammerling, G. H., E. Rusch, N. Tada, S. Kimura, and U. Hammerling. 1982. Localization of allodeterminants on H-2Kb antigens determined with monoclonal antibodies and H-2 mutant mice. Proc. Natl. Acad. Sci. USA 79:4737.
37. Schreiber, R. L., L. J. Hicks, A. Celeda, N. A. Buchmeier, and P. W. Grey. 1985. Monoclonal antibodies to murine γ-interferon which differentially modulate macrophage activation and antiviral activity. J. Immunol. 134:1609.
38. Belitsos, P. C., J. E. K. Hildreth, and J. T. August. 1990. Homotypic cell aggregation induced by anti-CD44(pgp-1 ) monoclonal antibodies and related to CD44(pgp-1) expression. J. Immunol. 144:1661.
39. Masellis-Smith, A., G. T. Jensen, J. G. Seehafer, J. R. Slupsky, and A. R. E. Shaw. 1990. Anti-CD9 monoclonal antibodies induce homotypic adhesion of pre-B cell lines by a novel mechanism. J. Immunol. 144:1607.
40. Schattner, E. J., K. B. Elkon, D. Yoo, J. Tumang, P. H. Krammer, M. K. Crow, and S. M. Freidman. 1995. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 182:1557.
41. Townsend, A., T. Elliot, V. Cerundolo, L. Foster, B. Barker, and A. Tse. 1990. Assembly of MHC class I molecules in vitro. Cell 62:285.
42. Kansas, G. S., G. S. Wood, and T. F. Tedder. 1991. Expression, distribution, and biochemistry of human CD39. J. Immunol. 146:2235.
43. Low, M. G. 1989. Glycosyl-phosphatidylinositol: a versatile anchor for cell surface proteins. FASEB J. 3:1600.
44. Wong, Y. W., and M. G. Low. 1994. Biosynthesis of glycosylphosphatidylinositol-anchored human placental alkaline phosphatase: evidence for a phospholipase C-sensitive precursor and its post-attachment conversion into a phospholipase C-resistant form. Biochem. J. 301:205.
45. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
46. Trauth, B. C., C. Klas, A. M. J. Peters, S. Matzku, P. Moller, W. Falk, K. Debatin, and P. H. Krammer. 1989. Monoclonal antibody mediated tumor regression by induction of apoptosis. Science 245:301.
47. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959.
48. Camerini, D., G. Walz, W. A. M. Loenen, J. Borst, and B. Seed. 1991. The T cell activation antigen CD27 is a member of the NGF/TNF receptor gene family. J. Immunol. 147:3165.
49. Calderhead, D. M., J. E. Buhlman, A. J. M. v. d. Eertwegh, E. Claassen, R. J. Noelle, and H. P. Fell. 1993. Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions. J. Immunol. 151:5261.
50. Durkop, H., U. Latza, M. Hummel, F. Eitelbach, B. Seed, and H. Stein. 1992. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421.
51. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J. P. Galizzi, C. v. Cooten, Y. J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881.
52. Stamenkovic, I., E. A. Clark, and B. Seed. 1989. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8:1403.
53. Jang, I. K., Z. H. Lee, Y. J. Kim, S. H. Kim, and B. S. Kwon. 1998. Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-κB. Biochem. Biophys. Res. Commun. 242:613.
54. Pollock, K. E., Y. Kim, Z. Zhou, J. Hurtado, K. K. Kim, R. T. Pickard, and B. S. Kwon. 1993. Inducible T cell antigen 4-1BB. J. Immunol. 150:771.
55. Bodmer, J., K. Burns, P. Schneider, K. Hofman, V. Steiner, M. Thome, T. Bornand, M. Hahne, M. Schroter, K. Becker, et al. 1997 TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas (apo-1/CD95). Immunity 6:79.
56. Marsters, S. A., J. P. Sheridan, C. J. Donahue, R. M. Pitti, C. L. Gray, A. D. Goddard, K. D. Bauer, and A. Ashkenazi. 1996. Apo-3, a new member of the tumor necrosis receptor family, contains a death domain and activates apoptosis and NF-κB. Curr. Biol. 6:1669.
57. Kitson, J., T. Raven, Y. Jiang, D. V. Goeddel, K. M. Giles, K. Pun, C. J. Grinham, R. Brown, and S. N. Farrow. 1996. A death domain containing receptor that mediates apoptosis. Nature 384:372.
58. Chinnaiyan, A. M., K. O'Rouke, G. Yu, R. H. Lyons, M. Garg, R. Duan, L. Xing, R. Gentz, J. Ni, and V. M. Dixit. 1996. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274:990.
59. Pan, G., K. O'Rourke, A. M. Chinnaiyan, R. Gentz, R. Ebner, J. Ni, and V. M. Dixit. 1997. The receptor for the cytotoxic ligand TRAIL. Science 276: 111.
60. Pan, G., J. Ni, Y. Wei, G. Yu, R. Gentz, and V. M. Dixit. 1997. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277: 815.
61. Sheridan, P., J., S. A. Marsters, R. M. Pitti, A. Gurney, M. Skubateh, D. Baldwin, L. Ramakrishnan, C. L. Gray, K. Baker, W. I. Wood, et al. 1997. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818.
62. Screaton, G. R., X. Xu, A. L. Olsen, A. E. Cowper, R. Tan, A. J. McMichael, and J. I. Bell. 1997. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 94:4615.
63. Hsu, H., I. Solovyev, A. Colombero, R. Elliot, M. Kelley, and W. J. Boyle. 1997. ATAR, a novel tumor necrosis receptor family member signals through TRAF2 and TRAF5. J. Biol. Chem. 272:13471.
64. Montgomery, R. I., M. S. Warner, B. J. Lum, and P. G. Spear. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427.
65. Brojatsch, J., J. Naughton, M. M. Rolls, K. Zingler, and J. A. T. Young. 1996. CAR1, a TNFR-related protein is a cellular receptor for cytopathic avian leukosis-sarcoma virus. Cell 87:845.
66. Bulow, G. U. v., and R. J. Bram. 1997. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 278:138.